Dr Rafael J Grossman leads the discussion at The Surgeon Show

‘We’ve been displaced by technology in healthcare, and we are forgetting about the human patient in front of us.’ That was the stark warning from Dr Rafael J Grossmann, renowned trauma surgeon and digital health pioneer, who was the keynote speaker at The Surgeon Show in London last month.

Celebrated for his innovative approach at the crossroads of healthcare and technology, Dr Grossmann captivated the audience with his passionate speech, emphasising the event’s importance as a pioneering platform for surgical innovation and collaboration.

He praised the event as ‘magnificent and most-needed’, expressing enthusiasm for how it showcased new robotic technology and AI applications in healthcare, as well as its facilitation of the ‘meeting of global minds’.

However, his main message was a cautionary one: implementing new technology in surgery cannot happen without considering the human element.

Dr Grossmann, a self-confessed ‘geek,’ was one of the earliest adopters of wearable technology in the operating room and has long been an advocate for digital innovation in surgery. He said he has ‘always been fascinated by the power and potential of technology to change how we do things’.

But he warned that ‘technology pushes us to forget the person in front of us’. For him, using AI, robotics, and new technologies intelligently means holding on to our humanity.

Speaking with the event’s media partners, Future Medicine, after his address, he said it was important to ‘use technology smartly in order to not forget that the primordial goal is that person in front of you’.

‘Technology is almost forcing us to do that unless we fight back,’ he added. ‘We forget to talk, we forget to inform. And the patient becomes a number, becomes a case, becomes a disease pathology rather than a human with disease.’

He also suggested that the profession itself can sometimes act as a barrier to the adoption of new technology. ‘There are cost barriers, there are regulatory barriers, and there are political barriers. But education is the main barrier – for the professionals, the regulators and the administrators. I’m a full-time evangelist, and if we don’t make it our goal to really change minds, it will never happen… we need to accelerate it because we have no time.’

He agreed that there can be a disconnect between surgical training and what medical students are exposed to, as well as the realities of clinical practice, and emphasised that the profession needs to update the curricula. The way surgery is taught, even in countries in the Global North, is decades out of date, he said, adding that it is a ‘paradigm that we need to figure out how to change’.

‘In the five to seven years of training, the world changes radically. Every day, there is something new in AI and robotics, so unless this is adapted and brought to the training of a new generation, playing catch-up only proves difficult and costly, contributing to burnout and affecting patient care.’

Elsewhere, the day’s discussions spanned all aspects of future surgery, including robotics, AI, and immersive technologies, as well as digital ethics, data-driven care, training, leadership, and mentorship in the modern era.

Attendees could access 25 curated, high-level sessions on recent advancements and challenges in surgery, offering excellent networking opportunities.

The exhibition, complementing the sessions, showcased a wide range of innovative surgical technologies, including artificial intelligence, digitalisation, virtual reality, 3D printing and robotics.

Successfully attracting an impressive 656 C-suite surgeons from around the world, the UK’s pioneering Surgical Leaders Summit has already cemented its place on the global surgical calendar.


‘The Surgeon Show truly sets the tone for what lies ahead, showcasing the very best of global robotic surgical practice with a clear focus on improving patient outcome’

London hosted the first-ever Surgeon Show on 20 February, igniting innovation, sparking collaboration and transforming the surgical community, earning itself a place on the global surgical calendar.

According to one guest, the pioneering and exclusive Surgical Leaders Summit ‘sets the tone for what lies ahead, showcasing the very best of global robotic surgical practice with a clear focus on improving patient outcomes’.

Designed to shape the future of surgery, drive change and elevate leadership within the profession, The Surgeon Show 2026 was held at the prestigious Minster Building in the heart of London’s financial district and attracted an impressive 656 C-suite surgeons from around the world.

It featured more than 60 expert speakers and distinguished faculty, drew clinicians from across the globe, and was supported by over 50 healthcare organisations.

The event provided an exceptional platform for learning, sharing and collaboration and, thanks to its impressive line-up of speakers and guests, it was perfectly placed to disseminate insights from some of the most influential voices in the sector.

Attendees participated in 25 curated, high-level sessions that addressed the latest advancements and challenges in surgery, offering exceptional networking opportunities.

The complementary exhibition showcased a wealth of cutting-edge surgical innovations, including those in artificial intelligence, digitalisation, virtual reality, 3D printing and robotics.

The keynote speaker was Rafael J Grossmann, the widely acclaimed general and trauma surgeon and pioneering digital health innovator, whose passion for the intersection of healthcare and technology was palpable in his address.

Hailed as a top influencer in digital health transformation, he described The Surgeon Show as a ‘magnificent and most-needed event’.

Among the key themes covered, delegates were treated to sessions on:
• The future operating theatre – integrating robotics
• AI and immersive technologies
• Digital ethics and data-driven care in an AI-enabled world
• Training, leadership and mentorship in the modern era.

Speaking after the event, Professor Shafi Ahmed, the multi-award-winning surgeon, educator, and innovator, and co-founder of Surgery International and The Surgeon Show, admitted he was overwhelmed by the response.

‘Thank you to all who came and supported The Surgical Leaders Summit at The Surgeon Show, which has found its permanent place in the surgical calendar,’ he said. ‘When we set out to build an entirely new event, we looked at the landscape and knew it was necessary. Our sole purpose was to connect senior surgeon leaders with industry partners and policymakers. We succeeded in our endeavours by creating an inspiring environment for the ultimate decision-makers to meet in one room to rethink, reimagine and redesign the future of our profession.’

He added: ‘Surgery presents unique challenges, and we wanted to take our guests on a journey that would push them out of their comfort zones and expand their minds and horizons – to create a different way of thinking and bring global perspectives. From mind-blowing keynotes to insightful panel discussions, from robots and exoskeletons to extended reality and AI surgical platforms, the agenda was created to inspire.’

Zameer Shah, a consultant orthopaedic surgeon at Guy’s and St. Thomas’ NHS Foundation Trust, summarised the mood: ‘Massive credit goes to Professor Shafi Ahmed and Mr Tim Lane (RCS President Elect), and the entire team who organised this visionary, informative, and collegial gathering, bridging the interfaces of surgery, healthcare, innovation and technology.’

He added: ‘From the powerful keynote by Dr Rafael J. Grossmann to the concluding reflections by Professor Aymeric Lim, Singapore, this was a truly international and inspiring event. It was a privilege to attend.’

Indeed, the feedback was overwhelmingly positive. Ryan Kerstein, surgeon and NHS innovation leader, remarked: ‘Thanks for creating The Surgeon Show as a space for honest conversations. Congratulations on delivering something genuinely different.’

Nikhil Vasdev, professor and chair of robotic surgery (HMS, UH), added: ‘Thank you for organising such a remarkable academic surgical event. The Surgeon Show truly sets the tone for what lies ahead, showcasing the very best of global robotic surgical practice with a clear focus on improving patient outcomes.’

Tim Lane, consultant urologist and robotic surgeon and the Royal College of Surgeons’ president elect and editor in chief of Surgery International, who co-founded the event, said: ‘Thanks go to all the global sponsors, exhibitors, and speakers, whose insights and expertise are shaping the future of surgery, who share our ambitions in helping build our responsible future together. Ultimately, we wanted to create something new, unique, disruptive and special.’

Professor Shafi added: ‘In the world of social media, visibility and brand awareness, we wanted to create lasting and powerful media, and our media team partnered with the brilliant team from Future Medicine. Together, we are shaping the next era of surgery, with innovation, responsibility and patients at the heart of every conversation. Let us think boldly, lead responsibly and build what comes next, together.’

Other sponsors were thanked, too, for supporting Surgery International in bringing The Surgeon Show to life. They included:
• Albright IP
• AV Medical Systems
• Cambridge Consultants
• CMR Surgical
• Concentric
• The Confederation of British Surgery
• DarwinGroup
• Erbe
• Healthcare Skills Training International
• J&J MedTech
• Medtronic
• Module CO
• Orascoptic
• Organa
• R2 Surgical
• Regency Wealth Management
• The Royal Society of Medicine
• Stanley
• Team
• VitVio.

An exoskeleton designed to reduce strain and combat muscular fatigue during long hours in the operating room could ease surgeons’ stress.

Kapil Sahnan, a UK colorectal surgeon at St Mark’s The National Bowel Hospital in London, is the first to wear the device during a seven-hour procedure.

The exoskeleton suit is worn over scrubs and designed to support the arms and shoulders during prolonged surgical procedures.

He said: ‘Surgery can be physically demanding, especially during longer procedures, which can last many hours and being hunched over an operating table is not great for your posture. This is a welcome piece of kit for surgeons.’

Andre Jutel from Stanley, specialist experts in this area, assessed Kapil’s movement using their ErgoScan app before the procedure.

The Hapo Front exoskeleton was recommended because it helps reduce fatigue and supports surgeons in working comfortably and with precision.

The lightweight exoskeleton, which comprises adjustable back, shoulder and arm straps, supports the wearer's musculoskeletal structure and maintains freedom of movement without restriction. 

Kapil said: ‘It’s good because you can maintain the dexterity of your hands while performing surgery. During the training, I did feel like I was being measured for a suit, but the exoskeleton is surprisingly easy to put on and adjust. It is certainly something I will be using again. We’re a specialised hospital with a small niche workforce, so we can’t afford to have surgeons going off sick with issues like muscular disorders, which is a common side effect of the profession.’

Graham Sharp, Managing Director of Stanley, added: ‘The fantastic feedback from Mr Sahnan and his team demonstrates how exoskeleton technology is supporting the profession, particularly during lengthy operations. We advised the team at St Mark's on the best technology for this type of procedure and supplied training along with the HAPO Front exoskeleton. 

‘AI-powered wearable technology is already revolutionising professional workflows across the healthcare sector, significantly mitigating physical fatigue. We are moving toward a future where exoskeleton equipment will be a standard fixture in operating theatres throughout the UK.’

A gathering of some of the most respected and forward-thinking minds in surgery will take place at The Surgeon Show 2026 on Friday, 20 February, at The Minster Building, Central London.

Positioned as one of the UK’s most influential surgical gatherings, this invitation-only, one-day summit will convene consultant surgeons, clinical directors, policymakers, healthcare innovators and technology leaders from across the UK and around the world.

Together, they will explore how robotics, artificial intelligence and advanced technologies are redefining modern surgical practice and shaping the future of patient care.

Headline partner Darwin Group supports the event, bringing its expertise in designing and building permanent-grade, on-demand healthcare facilities that enable trusts and organisations to deliver exceptional care.

The Surgeon Show 2026 has been awarded Ethical MedTech Accreditation and international CPD (Continuing Professional Development) accreditation by The CPD Certification Service. The accreditation recognises the event’s educational quality and provides formal professional recognition for attending surgeons worldwide.

Accredited delegates will receive five CPD points, contributing towards professional development requirements for regulatory bodies and membership organisations in the UK and internationally.

Designed as a curated, high-impact forum, the summit will bring together frontline clinical insight, system-level strategy and real-world innovation at scale. The programme reflects the rapid pace of transformation across surgery and healthcare systems worldwide.

Event highlights include:

Professor Shafi Ahmed, multi-award-winning surgeon, educator and global innovator, said:

“The Surgeon Show is more than an event, it’s a movement. We’re creating a space where the brightest minds in surgery can come together, challenge each other and shape the future of our profession. Every voice here matters, because the future of surgery depends on collaboration across disciplines, generations and technologies.

We are delighted to welcome more than 60 expert speakers from across the UK and internationally, representing over 50 NHS trusts, private providers, universities and global health systems. Across more than 25 curated sessions, with faculty from Europe, North America, Asia and the Middle East, the programme reflects the breadth and pace of change in surgery today.”

Among the standout sessions are:

Unlike traditional conferences, The Surgeon Show is designed to be conversational and collaborative, encouraging cross-disciplinary dialogue and practical insight into how technology and teamwork are transforming surgical practice.

Key themes for 2026 include:

Created to unite and inspire the surgical community, The Surgeon Show is a by-invitation-only summit for leaders shaping the next era of surgical care.

View the agenda here

Confirm your complimentary place here: 

Medtronic will bring its next-generation surgical robotics offering to The Surgeon Show, where attendees can see live demonstrations of the Hugo™ Robotic-Assisted Surgery (RAS) system alongside the company’s Touch Surgery™ digital training and education platform.

The appearance comes as Medtronic continues to expand the footprint of Hugo™ RAS internationally. The modular and portable system, developed for soft-tissue surgery—is now FDA cleared in the United States for urologic procedures and CE-marked for soft tissue abdominal procedures including urological, gynaecological, colorectal and general surgeries in Europe, positioning it as an increasingly prominent option in the fast-moving global robotic surgery landscape.

At the centre of Hugo™ RAS is a modular design built around independent arm carts, enabling teams to configure the system from one to four robotic arms depending on the needs of each case. The platform also features an open surgeon console, intended to support greater communication and coordination between the surgeon and the wider operating theatre team.

Medtronic says the flexible set-up supports multi-quadrant access, allowing teams to tackle more complex procedures while helping maintain smooth workflow - particularly in environments where space, set-up time and adaptability are key operational priorities.

Vanessa Lowe, Senior Business Unit Director, Medtronic Surgical, UK and Ireland: “At The Surgeon Show, we’re looking forward to demonstrating how Hugo™ RAS has been designed to fit into real clinical environments, bringing modularity, flexibility and choice to robotic-assisted surgery. By integrating Touch Surgery™ training and post-operative analytics, we’re also helping teams build skills and insight that support continuous improvement, both in and beyond the operating theatre.”

Alongside the robotics hardware, Medtronic will also highlight integration with Touch Surgery™ Enterprise, a cloud-based platform that combines interactive training content, surgical video recording, live streaming, and post-operative analytics designed to support surgeon education and performance improvement.

The company will also showcase the LigaSure™ Maryland RAS vessel-sealing instrument, CE-marked in 2025 for use with Hugo™ RAS, bringing its established vessel‑sealing capability into a robotic‑assisted setting.

Visitors to Medtronic’s booth at The Surgeon Show will be able to see the Hugo™ RAS system in action, alongside demonstrations of Touch Surgery™ live streaming, providing a hands-on view of how robotic platforms, training tools and analytics are increasingly converging to support modern surgical practice.

The Surgeon Show 2026 will bring together senior surgical leaders and industry innovators for a programme shaped around conversation and debate, exploring the issues influencing the future of surgery - from the operating theatre of tomorrow to the growing role of AI, robotics and advanced technologies in clinical practice.

The event is invitation-only, with registration of interest available via surgeonshow.com.

Disclaimers

The Medtronic Hugo™ RAS system is commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, or market availability. Indications for use may vary. Risks may include arrythmia, bleeding, burns, infection, tissue damage or other complications.

The Medtronic Touch Surgery™ ecosystem is not intended to direct surgery, or aid in diagnosis or treatment of a disease or condition. Please note: Performance Insights are available for select procedures, instruments, and anatomy.

The Surgeon Show 2026, with Healthcare Skills Training International, has been awarded international CPD (Continuing Professional Development) accreditation by The CPD Certification Service.

The accreditation confirms the event’s educational quality and provides formal professional recognition for attending surgeons worldwide.

The one-day conference takes place on Friday, 20 February 2026, at The Minster Building, London, bringing together surgeons, healthcare innovators and technology leaders to explore the future of surgical practice.

Accredited delegates will receive five CPD points, which can be used towards CPD requirements for professional bodies, regulators and membership organisations in the UK and internationally.

Professor Shafi Ahmed, one of the hosts of The Surgeon Show, said: “Securing CPD accreditation with Healthcare Skills Training International (HSTI) validates the rigour of our programme and ensures surgeons receive meaningful recognition for their professional development.”

The Surgeon Show 2026 programme focuses on the clinical, technological and leadership challenges shaping modern surgery, including:

The programme features internationally recognised speakers including Professor Shafi Ahmed, Professor Nikhil Vasdev, Professor Aymeric Lim and Professor Yujia Gao, alongside senior leaders from NHS trusts and global medtech companies.

The event will run across three concurrent theatres and include keynote presentations, panel discussions, innovation spotlights, industry-led sessions and structured networking opportunities, including breakfast sessions and an evening reception.

To achieve CPD accreditation, HSTI demonstrated that The Surgeon Show 2026 meets strict quality assurance criteria, including:

Tim Lane added: “This accreditation reflects the commitment of our advisory board and speakers to advancing surgical knowledge and practice. Our ambition is to establish The Surgeon Show as the premier CPD-accredited event for the global surgical community.”

Healthcare Skills Training International is dedicated to providing professional clinical education to post-graduate clinicians, allied healthcare professionals and device industry product support professionals. We believe that everyone in an acute care setting should have formal training to support patient safety, all ethical and legal requirements and clinical effectiveness. 

All registered delegates will receive a CPD Certificate of Attendance after the event.

The Surgeon Show 2026 will bring together senior surgical leaders and industry innovators for a programme shaped around conversation and debate, exploring the issues influencing the future of surgery - from the operating theatre of tomorrow to the growing role of AI, robotics and advanced technologies in clinical practice.

The event is invitation-only, with registration of interest available via surgeonshow.com.

Cambridge Consultants, the deep tech powerhouse of Capgemini, has been confirmed as sponsor of the opening breakfast session at The Surgeon Show 2026, bringing together surgeon-innovators to discuss what it takes to turn clinical insight into scalable medtech solutions.

The session, titled “The Key to MedTech Success with Cambridge Consultants”, will take place at 8:30am and will examine the innovation-to-commercialisation journey from identifying an unmet need in surgery, through product build and investment, to revenue generation, adoption and growth.

Chaired by Oliver Sowerby, Vice President of MedTech Innovation at Cambridge Consultants, the breakfast panel will feature clinical innovators at different stages of company and product development, including:

The session will open with a short talk, followed by a panel discussion focused on a core theme: why clinical workflow matters and why even well-funded projects can fail if technologies don’t work in real surgical settings.

Commenting on the session, Oliver Sowerby said: “Surgeon-innovators are uniquely positioned to identify unmet needs, but building a company around that insight brings new challenges from engineering and regulation to investment and adoption. We’re proud to support this session and help create an open, honest conversation about what success really looks like in medtech.”

The panel will explore how surgeons are translating frontline insight into technology-led ventures, and the practical challenges that emerge as innovations scale — including product development, regulatory pathways, funding, clinical adoption and commercial growth.

The Surgeon Show 2026 will bring together senior surgical voices and industry leaders for a programme designed around conversation and debate, covering topics shaping the future of surgery - from the operating theatre of tomorrow to the growing role of AI, robotics and advanced technologies in clinical practice.

The event is invitation-only, with registration of interest available via surgeonshow.com.

The Surgeon Show 2026 has revealed the full scientific agenda for its flagship summit, set to take place on Friday, 20 February 2026 at The Minster Building in Central London.

Positioned as one of the UK’s most influential surgical gatherings, the one-day summit will convene consultant surgeons, clinical directors, policymakers and innovators from the UK and around the world to examine how robotics, artificial intelligence and advanced surgical technologies are redefining modern surgical practice.

Designed as a high-impact, curated forum, the event aims to help shape the next era of surgery, bringing together frontline clinical insight, system-level strategy and real-world innovation at scale.

Speaking ahead of the summit, Professor Shafi Ahmed, Consultant Surgeon, said: “We are delighted to welcome more than 60 expert speakers from across the UK and internationally, representing over 50 NHS trusts, private providers, universities and global health systems. Across 25+ curated sessions, with international faculty from Europe, North America, Asia and the Middle East, the programme reflects the breadth and pace of change in surgery today.”

Among the standout sessions are:

View the agenda here

Confirm your complimentary place here: 

By Professor Shafi Ahmed

Surgeon | Futurist | Innovator | Entrepreneur | Humanitarian | Intnl Keynote Speaker

As we close the final chapter of 2025, we stand at a pivotal moment in the evolution of artificial intelligence in healthcare. This year will be remembered not for isolated breakthroughs but for the integration of AI into the very fabric of clinical care, research, and health systems globally. What we've witnessed isn't just incremental improvement but a fundamental shift in the field.

In this end of year newsletter, I have summarised the most consequential developments of the year, particularly innovations that have reshaped diagnostics, workflow automation, predictive medicine, and AI governance, and tried to offer insights into the narratives that will shape 2026 and beyond.

From Experimental Tools to Mainstream Adoption:

Throughout 2025, AI moved from pilots and proofs of concept to enterprise-grade systems embedded in clinical workflows. Health systems progressed from experimentation to operational deployment of AI assistants, ambient scribes, and diagnostic augmentation tools, demonstrating measurable impact on clinician workflow and patient outcomes.

The 2025 HCI Innovation Group report documented rapid adoption: 22 % of healthcare organisations now use domain-specific AI tools, a sevenfold increase over 2024, with ambient clinical documentation ($600 M) and coding automation ($450 M) among the fastest-growing categories. This reinforces that AI is no longer niche. It’s becoming foundational infrastructure, analogous to EHRs or PACS a decade ago. The adoption curve in 2025 seemingly reflects scale, not hype.

Multimodal & Generative AI as Clinical Partners:

One of the central themes of 2025 was the refinement of multimodal artificial intelligence: systems that integrate text, imaging, structured data, and signals to support robust clinical reasoning. Multimodal AI in healthcare enhances trust and usability by combining text and medical images for transparent decision-making. The XMedGPT system grounds anatomical references visually, quantifies uncertainty, and improves prognostic accuracy. Rigorous benchmarking demonsatrated superior general ability, positioning "multimodal explainable AI" as vital for reliable, clinician-centric support across diverse medical applications.

Similarly, comprehensive reviews in 2025 (e.g., Natural Language Generation in Healthcare) underscored how generative methods are now core to automated documentation and summarisation, conversational clinical agents, synthesising heterogeneous data modalities, and enabling reasoning without losing contextual nuance.

Ambient Intelligence — Clinician Workload and Presence:

The most tangible impact this year has been on clinician workflow, which is the advancement of Ambient AI, which is quietly transforming healthcare by embedding intelligence directly into clinical workflows without disrupting human interaction. Using technologies such as NLP, speech recognition, machine learning, and EHR integration, ambient systems document encounters, issue reminders, and predict risks in real time. Tools like ambient AI scribes reduce documentation time, lower clinician burnout, and restore face-to-face patient care. This was supported by multi-center studies, including JAMA Network Open reports showing real-world reductions in EHR time and improved clinician wellbeing.

Beyond clinics, ambient AI supports predictive monitoring, post-operative care, and home-based chronic disease management. While offering strong cost-effectiveness and global scalability, its success depends on ethical governance, transparency, explainability, and thoughtful integration that enhances, rather than replaces, clinical judgment and empathy.

Predictive and Preventive Medicine: From Forecasting to Real-Time Intervention

A defining trend of 2025 was the shift of AI from diagnostic tools to systems enabling predictive and preventive medicine. This moves clinicians into proactive health forecasting, with major implications for chronic disease management and personalised care. Advances such as Delphi-2M enable long-term disease forecasting using multimodal data, while frontline tools like AI-enabled stethoscopes and ECG-based models (EchoNext, AdaCVD) allow earlier detection of cardiovascular disease. AI is also improving early diagnosis of cancer, Alzheimer’s disease, dementia risk, mental health crises, and reproductive health conditions. These technologies promise targeted prevention, reduced healthcare burden, and improved outcomes across time horizon, from minutes to decades.

However, challenges remain around clinical validation, explainability, bias, ethics, and equitable global deployment to ensure AI reduces, rather than reinforces, health disparities.

Diagnostics & Imaging: AI Uncovers Hidden Signals

In 2025, AI fundamentally advanced diagnostics by moving beyond pattern recognition to integrated clinical reasoning. AI-enabled sensors, including smart stethoscopes, demonstrated rapid detection of heart failure, valvular disease, and arrhythmias, doubling diagnostic yield in frontline settings. Multi-disease diagnostic engines expanded AI’s scope across cancer, cardiovascular, neurological, and infectious diseases, while digital twin technologies enabled simulated treatment pathways, supporting truly personalized care.

Crucially, AI began to engage in diagnostic dialogue. AMIE, a conversational diagnostic system, outperformed primary care physicians across accuracy, empathy, and reasoning in OSCE-style trials, while MAI-DxO achieved over 85% accuracy on complex cases, far exceeding human clinicians and reducing diagnostic costs. In imaging and pathology, AI matched or surpassed specialists: diagnosing celiac disease from biopsy slides with >95% accuracy and detecting structural heart disease from routine ECGs via EchoNext. Together, these advances signal a shift toward holistic, reasoning-driven diagnostics at scale.

AI in Mental Health Care:

Mental health care emerged as one of the most transformative frontiers for AI in 2025. Amid global workforce shortages and rising demand, AI expanded access through early risk detection, personalised therapy, and always-available digital support. Advances in speech, text, behavioural, and biometric analysis enabled earlier identification of depression, anxiety, psychosis, and suicide risk, while AI-powered chatbots and hybrid human-AI platforms delivered scalable, stigma-free care. Wearables and predictive models improved relapse prevention and treatment precision. Yet, 2025 also underscored the importance of ethical deployment, prioritizing privacy, bias mitigation, transparency, and human oversight, positioning AI as a force multiplier for compassion, not a replacement for it.

AI in Surgery and Robotic-Assisted Procedures: Precision, Efficiency, and Outcomes

In 2025, AI has become integral to surgical practice, enhancing precision, safety, and efficiency. AI-powered robotic platforms supported complex procedures through real-time guidance, predictive analytics, and automated instrument control, reducing complications and operative time. Preoperative planning and intraoperative imaging are optimized with AI, while workflow automation and documentation free surgeons to focus on critical decision-making. Computer-assisted surgery (CAS) analyzes medical images, tracks instruments, and simulates procedures, enabling surgeons to anticipate challenges and make informed decisions. Platforms like the da Vinci and Vicarious Surgical systems enable minimally invasive surgeries with high accuracy, augmented reality overlays, real-time feedback, and predictive analytics. Solutions such as Medtronic’s Touch Surgery Ecosystem extend AI support beyond the operating room, turning complex data into actionable insights. This convergence of AI and robotics represents a paradigm shift, reshaping surgical practice, patient outcomes, and training of the next generation of surgeons. One of the most exciting young companies is VitVio who have raised 8 million Euros to continue building the smart operating theatre to enhance efficency.

Accelerating Drug Discovery and Development

Perhaps one of the most transformative impacts of AI in 2025 has been in the pharmaceutical sector. The traditional, decade-long, multi-billion dollar drug discovery process is being radically compressed. Generative AI models are being used to design entirely new molecular structures with desired therapeutic properties, opening up a vast design space previously inaccessible to chemists. AI algorithms are analysing massive datasets of genetic and molecular information to predict how potential drugs will behave in the human body, identifying promising candidates faster and with a higher probability of success. This is the beginning of the digital twin.

Companies like Insilico Medicine and Exscientia continued to lead this revolution, with multiple AI-designed drugs progressing through human clinical trials in 2025, a feat that was unimaginable just a few years ago. The timelines for moving from target identification to clinical trials are being cut from years to months.

Market Growth & Economic Landscape

In 2025, AI has transitioned from a clinical adjunct to a foundational economic driver in healthcare. Facing rising costs, workforce constraints, and chronic disease burdens, health systems leveraged AI to reduce inefficiencies across diagnostics, administration, drug development, and care delivery. AI-powered imaging, predictive analytics, and early diagnosis lowered downstream costs, while automation in billing, coding, triage, and call centres redirected resources toward high value clinical care.

The economic impact is evident in market growth. The 2025 AI in Healthcare Market Report projects global AI healthcare revenues rising from USD 21.66 billion in 2025 to USD 110.61 billion by 2030, a 38.6% CAGR, reflecting both commercial confidence and strategic investment in scalable, clinically validated solutions. AI augmented rather than replaced clinicians, enhancing decision support, operative guidance, digital pathology, and documentation automation, aligning with value-based care through personalised treatment, predictive prevention, reduced readmissions, and data-driven reimbursement.

AI Governance in Healthcare: From Fragmentation to Convergence

In 2025, AI regulation in healthcare has shifted from exploratory frameworks to active enforcement and convergence, though fragmentation remains. The EU AI Act moved into early implementation, formally classifying medical AI as high-risk and mandating transparency, post-market surveillance, bias mitigation, and human oversight. The UK advanced adaptive AI regulation through MHRA reforms, expanding real-world monitoring for continuously learning systems. In the US, while no single federal law emerged, the FDA strengthened lifecycle oversight for AI/ML medical devices, coordinated with HHS, FTC, and NIST, and issued clearer guidance on generative AI in clinical decision support. South Korea enacted a full AI framework law, while India accelerated governance around deepfakes, health data, and AI-assisted decision-making. Collectively, 2025 marked a turning point: regulators moved from principles to practice, recognizing that safe, ethical, and explainable AI is essential to scale innovation, positioning regulation not as a brake on progress, but as its enabler.

Human-AI Collaboration — Not Replacement

AI in healthcare is increasingly viewed as an augmentative partner rather than a replacement for clinicians. Its strengths lie in automating administrative tasks, analysing vast datasets, and streamlining workflows, enabling doctors to focus on patient care and reduce burnout. Generative AI tools integrated into electronic medical records, for example, help draft clinical notes, schedule appointments, and manage data efficiently.

AI also demonstrates strong diagnostic capabilities, personalized treatment planning, and clinical trial optimisation. Studies show that while AI can outperform traditional tools in specific tasks, human oversight remains essential; empathy, ethical judgment, and patient rapport are irreplaceable. Ethical considerations, including privacy, bias, and transparency, are critical as AI becomes more embedded in healthcare.

However, AI’s promise depends heavily on accessible, high-quality data.

Advances in federated learning, privacy-preserving computation, and data standardisation have improved the ability of models to learn from distributed data without compromising privacy, but fragmentation persists, especially in low-resource settings.

Interoperability and standardised data pipelines remain major barriers, and addressing these is urgent for health systems and regulators.

In the immediate near future of healthcare, lies human-AI collaboration: clinicians leveraging AI insights while retaining decision-making authority, ensuring efficiency, accuracy, and patient-centred care.

Looking Forward — Priorities for 2026

As we move into 2026, the integration of AI in healthcare must evolve from proof-of-concept to measurable impact on patient outcomes. While high diagnostic accuracy and reduced administrative burden have been achieved, the next frontier is demonstrating that AI tangibly improves morbidity, mortality, and readmissions and reduces health disparities. Evidence-based deployment will be critical to validate AI’s true contribution to patient care.

Rigorous, adaptive evaluation will also be essential. AI systems that continue to learn while deployed must be monitored with robust safety gates, ensuring that performance remains reliable and clinically safe. Regulatory frameworks and quality assurance protocols will need to keep pace with these dynamic technologies to maintain trust and accountability.

Equity-first design will define AI’s role in 2026. Models must be validated across diverse populations to ensure fairness, accessibility, and universal benefit, avoiding bias that could exacerbate existing healthcare inequalities.

Finally, lifelong AI literacy will be vital for clinicians. Healthcare professionals must be fluent in interpreting AI outputs, understanding model limitations, and exercising ethical judgment in AI-assisted care. Moving forward, 2026 will mark a year where AI and human expertise converge meaningfully, enhancing outcomes, fostering equity, and redefining the standard of patient-centred healthcare.

As we conclude this year, let us all commit to responsible innovation, measured adoption, and iterative learning, hallmarks of both good medicine and good AI.

Darwin Group®, a leading healthcare estate specialist, has been announced as the Headline Sponsor of The Surgeon Show 2026, reinforcing its commitment to supporting surgical teams and tackling capacity challenges across the health sector.

The Surgeon Show brings together surgeons, healthcare leaders and industry partners to explore innovation, best practice and the future of surgery in the UK. As headline sponsor, Darwin Group will play a central role in showcasing how permanent-grade, adaptable healthcare facilities can help organisations deliver exceptional patient care – without compromise.

Darwin Group solves complex healthcare estate problems by designing and building permanent-grade On-Demand® healthcare facilities, enabling NHS trusts and private healthcare organisations to respond quickly to pressure points such as elective care backlogs, ageing infrastructure and refurbishment programmes. Its range of adaptable clinical and non-clinical buildings are designed to integrate seamlessly with existing estates, while eradicating the burden of future backlog maintenance.

Commenting on the sponsorship, Nick Dawe, Managing Director from Darwin Group said: “The Surgeon Show is an important platform for meaningful conversations about the realities facing surgical teams today. We’re proud to be the headline sponsor for 2026 and to support a community that is focused on delivering safe, high-quality care in increasingly challenging environments. Our role is to provide permanent-grade solutions that give clinicians the right space to operate, without compromise on safety, quality or staff wellbeing.”

A key focus at The Surgeon Show 2026 will be Darwin Group’s On-Demand Ultraclean Operating Theatre – a hireable theatre solution that delivers permanent quality for as long as it is needed. Designed to HBN and HTM standards, the facility features a solid concrete floor, compliant operating space and an Ultraclean Ventilation System providing controlled laminar airflow with HEPA filtration.

Darwin Group have worked with industry leading partners to achieve a surgical space that is indiscernible from a permanent operating theatres

Unlike traditional temporary solutions, the On-Demand Operating Theatre enables surgical teams to carry out a wide range of procedures, including orthopaedic, cardiothoracic, neurosurgery and other high-risk surgeries, with no compromise on patient safety, clinical performance or staff comfort.

Staff wellbeing is also a core consideration. The theatre includes natural light via integrated windows, along with built-in Bluetooth audio to support a positive and comfortable working environment for surgical teams.

Available as either an extension to an existing hospital estate or as the heart of an independent surgical hub, the On-Demand Operating Theatre can support additional theatre capacity, decant and refurbishment programmes, or targeted elective recovery initiatives. Darwin Group also offers a full range of supporting facilities, including first-stage recovery bays, inpatient bed accommodation, CSSD units, reception and waiting areas, discharge lounges, staff welfare spaces and plant rooms – all tailored to the needs of each organisation.

By sponsoring The Surgeon Show 2026, Darwin Group continues to demonstrate its commitment to supporting the surgical community with practical, high-quality solutions that address today’s pressures while building resilience for the future.

surgery
connecting surgeons. shaping the future
AboutContact
Register
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram